[English] 日本語
Yorodumi- PDB-11ft: Structure of GDP-bound KRAS-G12C/Q99L, a Switch-II Pocket Inhibit... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 11ft | ||||||
|---|---|---|---|---|---|---|---|
| Title | Structure of GDP-bound KRAS-G12C/Q99L, a Switch-II Pocket Inhibitor Resistance Mutant | ||||||
Components | GTPase KRas | ||||||
Keywords | SIGNALING PROTEIN / RAS / oncogenic mutation / drug resistance | ||||||
| Function / homology | Function and homology informationresponse to mineralocorticoid / GMP binding / LRR domain binding / response to gravity / myoblast proliferation / cardiac muscle cell proliferation / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / GTPase complex ...response to mineralocorticoid / GMP binding / LRR domain binding / response to gravity / myoblast proliferation / cardiac muscle cell proliferation / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / GTPase complex / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / protein phosphatase type 1 complex / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / Signalling to RAS / negative regulation of programmed cell death / serine/threonine protein kinase complex / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / positive regulation of Ras protein signal transduction / response to isolation stress / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR4 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / Signaling by CSF3 (G-CSF) / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / p38MAPK events / FRS-mediated FGFR1 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / Signaling by FLT3 fusion proteins / SHC1 events in EGFR signaling / FLT3 Signaling / EGFR Transactivation by Gastrin / Signaling by FGFR1 in disease / NCAM signaling for neurite out-growth / liver development / CD209 (DC-SIGN) signaling / positive regulation of TOR signaling / GRB2 events in ERBB2 signaling / Downstream signal transduction / response to glucocorticoid / Insulin receptor signalling cascade / SHC1 events in ERBB2 signaling / Constitutive Signaling by Overexpressed ERBB2 / Ras activation upon Ca2+ influx through NMDA receptor / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / canonical NF-kappaB signal transduction / VEGFR2 mediated cell proliferation / small monomeric GTPase / endomembrane system / FCERI mediated MAPK activation / female pregnancy / Signaling by ERBB2 TMD/JMD mutants / Constitutive Signaling by EGFRvIII / Signaling by SCF-KIT / RAF activation / Signaling by high-kinase activity BRAF mutants / Signaling by ERBB2 ECD mutants / MAP2K and MAPK activation / Signaling by ERBB2 KD Mutants / cytokine-mediated signaling pathway / Signaling by RAF1 mutants / Signaling by CSF1 (M-CSF) in myeloid cells / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / MAPK cascade / Negative regulation of MAPK pathway / Regulation of RAS by GAPs / RAS processing / positive regulation of cellular senescence / Signaling by BRAF and RAF1 fusions / GDP binding / DAP12 signaling / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants / regulation of cell population proliferation / RAF/MAP kinase cascade / G protein activity / Ca2+ pathway / cytoplasmic side of plasma membrane / Ras protein signal transduction / positive regulation of MAPK cascade / mitochondrial outer membrane Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.16 Å | ||||||
Authors | Whitley, M.J. / Simanshu, D.K. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Nat Commun / Year: 2026Title: Structural mechanisms underlying resistance to Switch-II pocket inhibitors in KRAS Authors: Whitley, M.J. / Dyba, M. / Chakrabarti, M. / Smith, B.P. / Chan, A.H. / Denson, J.P. / Messing, S.A. / Lin, K. / Cornilescu, G. / Balius, T.E. / Nissley, D.V. / McCormick, F. / Maciag, A.E. / Simanshu, D.K. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 11ft.cif.gz | 89.4 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb11ft.ent.gz | 64.9 KB | Display | PDB format |
| PDBx/mmJSON format | 11ft.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/1f/11ft ftp://data.pdbj.org/pub/pdb/validation_reports/1f/11ft | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 11esC ![]() 11fbC ![]() 11flC ![]() 11fuC ![]() 11ghC C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 19343.865 Da / Num. of mol.: 1 / Mutation: G12C,Q99L,C118S Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: ![]() |
|---|---|
| #2: Chemical | ChemComp-MG / |
| #3: Chemical | ChemComp-GDP / |
| #4: Water | ChemComp-HOH / |
| Has ligand of interest | Y |
| Has protein modification | N |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 1.89 Å3/Da / Density % sol: 35.07 % |
|---|---|
| Crystal grow | Temperature: 293 K / Method: vapor diffusion, sitting drop / Details: 30% w/v PEG MME 5000, 0.1 M sodium acetate pH 4.5 |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: SSRL / Beamline: BL12-1 / Wavelength: 0.9795 Å |
| Detector | Type: DECTRIS EIGER2 XE 16M / Detector: PIXEL / Date: Mar 26, 2025 |
| Radiation | Monochromator: Si(111) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.9795 Å / Relative weight: 1 |
| Reflection | Resolution: 1.16→28.19 Å / Num. obs: 49307 / % possible obs: 95.3 % / Redundancy: 10.9 % / Biso Wilson estimate: 11.85 Å2 / CC1/2: 0.999 / CC star: 1 / Rmerge(I) obs: 0.065 / Rpim(I) all: 0.02 / Rrim(I) all: 0.068 / Net I/σ(I): 18.5 |
| Reflection shell | Resolution: 1.16→1.18 Å / Redundancy: 6.3 % / Rmerge(I) obs: 0.41 / Mean I/σ(I) obs: 4.2 / Num. unique obs: 1762 / CC1/2: 0.941 / CC star: 0.985 / Rpim(I) all: 0.1756 / Rrim(I) all: 0.447 / % possible all: 62.2 |
-
Processing
| Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENT / Resolution: 1.16→28.19 Å / SU ML: 0.07 / Cross valid method: THROUGHOUT / σ(F): 1.39 / Phase error: 14.93 / Stereochemistry target values: ML
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 88.62 Å2 / Biso mean: 17.0343 Å2 / Biso min: 7.48 Å2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: final / Resolution: 1.16→28.19 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 18
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
United States, 1items
Citation




PDBj






















